Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | cytochrome P450, family 19, subfamily A, polypeptide 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma cruzi | cytochrome P450, putative | cytochrome P450, family 19, subfamily A, polypeptide 1 | 503 aa | 425 aa | 18.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0042 | 0.0042 |
Echinococcus multilocularis | 6 phosphofructo 2 kinase:fructose 2 | 0.0443 | 1 | 1 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0019 | 0.0112 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0435 | 0.9826 | 0.9824 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0443 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0042 | 0.0042 |
Plasmodium falciparum | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0112 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0254 | 0.5595 | 0.5595 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0016 | 0.0042 | 0.0499 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0112 | 0.5 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase-1-like protein | 0.0189 | 0.4081 | 0.4014 |
Trichomonas vaginalis | ap endonuclease, putative | 0.0019 | 0.0112 | 0.5 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0042 | 0.0042 |
Entamoeba histolytica | phosphoglycerate mutase family protein, putative | 0.0261 | 0.5769 | 1 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0019 | 0.0112 | 0.1345 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0435 | 0.9826 | 0.9824 |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0042 | 0.0042 |
Loa Loa (eye worm) | hypothetical protein | 0.0016 | 0.0042 | 0.0042 |
Schistosoma mansoni | hypothetical protein | 0.0034 | 0.0466 | 0.0466 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0016 | 0.0042 | 0.0042 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0019 | 0.0112 | 0.0112 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0019 | 0.0112 | 0.5 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0112 | 0.0112 |
Loa Loa (eye worm) | hypothetical protein | 0.0435 | 0.9826 | 0.9826 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0019 | 0.0112 | 0.0112 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0019 | 0.0112 | 0.0194 |
Loa Loa (eye worm) | hypothetical protein | 0.0443 | 1 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0261 | 0.5769 | 1 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0189 | 0.4081 | 0.4014 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.005 | 0.0831 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.0831 | 0.0831 |
Mycobacterium ulcerans | fructose-2,6-bisphosphatase GpmB | 0.0261 | 0.5769 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0019 | 0.0112 | 0.0112 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0034 | 0.0466 | 0.5603 |
Schistosoma mansoni | 6-phosphofructokinase | 0.0443 | 1 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0042 | 0.0042 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0016 | 0.0042 | 0.0042 |
Giardia lamblia | Hypothetical protein | 0.0261 | 0.5769 | 1 |
Onchocerca volvulus | 0.0443 | 1 | 1 | |
Schistosoma mansoni | hypothetical protein | 0.0016 | 0.0042 | 0.0042 |
Giardia lamblia | Hypothetical protein | 0.0261 | 0.5769 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0016 | 0.0042 | 0.0499 |
Toxoplasma gondii | exonuclease III APE | 0.0019 | 0.0112 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0016 | 0.0042 | 0.0042 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0443 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0019 | 0.0112 | 0.5 |
Trypanosoma brucei | 6-phosphofructo-2-kinase 2 | 0.0435 | 0.9826 | 0.9824 |
Echinococcus multilocularis | GPCR, family 2 | 0.0016 | 0.0042 | 0.0042 |
Leishmania major | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0443 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.005 | 0.0831 | 0.0831 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0016 | 0.0042 | 0.0042 |
Plasmodium vivax | AP endonuclease (DNA-[apurinic or apyrimidinic site] lyase), putative | 0.0019 | 0.0112 | 0.5 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0189 | 0.4081 | 0.4014 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.005 | 0.0831 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase 1 | 0.0435 | 0.9826 | 0.9824 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.0466 | 0.0466 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0019 | 0.0112 | 0.0112 |
Trypanosoma brucei | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0443 | 1 | 1 |
Trypanosoma cruzi | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase, putative | 0.0189 | 0.4081 | 0.4014 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | = 18.5 uM | Growth inhibition of estrogen-sensitive human MCF7 cells after 72 hrs by MTT assay | ChEMBL. | 24025069 |
IC50 (binding) | Inhibition of human CYP17 expressed in Escherichia coli using progesterone as substrate NADPH as cofactor | ChEMBL. | 24025069 | |
IC50 (binding) | Inhibition of human CYP11B1 using [1,2-3H]-11-deoxycorticosterone as substrate | ChEMBL. | 24025069 | |
IC50 (binding) | > 10000 nM | Inhibition of aromatase (unknown origin) using 7-methoxy-4-trifluoromethylcoumarin as substrate after 30 mins by fluorimetric analysis | ChEMBL. | 24025069 |
Inhibition (binding) | Inhibition of CYP19 in human H295R cells using [1beta-3H(N)]-androst-4-ene-3,17-dione at 10 uM after 24 hrs by tritiated water release assay | ChEMBL. | 24025069 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.